Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: lysosome

July 4, 2023 CD as API / CD derivatives / Pharma applications

Lysosomal Targeting of β-Cyclodextrin

β-Cyclodextrin (β-CD) and derivatives are approved therapeutics in >30 clinical settings. β-CDs have also shown promise as therapeutics for treatment

Continue reading

November 18, 2022 Analysis / Non-pharma applications

HPBCD-enabled metal nanoclusters for selective labeling of lysosomes

The controllable self-assembly of metal nanoclusters (NCs) has attracted great interest because of the morphological versatility and accompanying luminescence properties,

Continue reading

July 7, 2022 CD derivatives / Drug delivery / Pharma applications

C60-β-cyclodextrin conjugates for enhanced nucleus delivery of doxorubicin

 Water-soluble C60-β-cyclodextrin conjugates were prepared to encapsulate and deliver doxorubicin to the cell nucleus. The behaviour of the fullerene aggregates

Continue reading

January 26, 2022 CD as API / CD derivatives / Pharma applications

Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis

Cholesterol crystals (CCs), originally accumulating in the lysosome of cholesterol-laden cells, can aggravate the progression of atherosclerosis. β-cyclodextrin (CD) is

Continue reading

February 6, 2020 CD as API / Pharma applications

Antiviral effect of C-reactive polymer and methyl beta-cyclodextrin via blocking autophagy through interactions with cell membrane cholesterol

Spanish researchers recently published on the mechanisms involved in antiviral activity of zebrafish C-reactive protein-like protein (CRP1-7) against the spring

Continue reading

Recent Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (362)
  • CD derivatives (446)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,245)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Obituary for Prof. Dr.-Ing. Wolfram Saenger
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin?
  • Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function
  • Effects of water matrix constituents on micropollutant removal by activated carbon and b-cyclodextrin polymer adsorbents
  • Green Extraction Techniques of Bioactive Compounds: A State-of-the-Art Review
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...